RFX5 antibody
Principal name
RFX5 antibody
Alternative names for RFX5 antibody
Regulatory factor X 5, DNA-binding protein RFX5
SwissProt ID
P48382 (Human)
Gene ID
5993 (RFX5)
Ncbi ID
NP_001020774, NP_000440, 9606, NP_000440.1, NM_000449, NM_001025603
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB), Enzyme Immunoassay (E), ELISA (detection) (E(detection)), Immunoprecipitation (IP), Electrophoretic Mobility Shift Assay (EMSA)
Background of RFX5 antibody
RFX5 is the fifth member of the growing family of DNA-binding proteins sharing a novel and highly characteristic DNA-binding domain called the RFX motif. RFX is a nuclear protein complex that binds to the X box of MHC-II promoters. The lack of RFX binding activity in complementation group C results from mutations in the RFX5 gene encoding the 75-kD subunit of RFX.A lack of MHC-II expression results in a severe immunodeficiency syndrome called MHC-II deficiency, or the bare lymphocyte syndrome (BLS; MIM 209920). At least 4 complementation groups have been identified in B-cell lines established from patients with BLS. The molecular defects in complementation groups B, C, and D all lead to a deficiency in RFX.A lack of MHC-II expression results in a severe immunodeficiency syndrome called MHC-II deficiency, or the bare lymphocyte syndrome (BLS; MIM 209920). At least 4 complementation groups have been identified in B-cell lines established from patients with BLS. The molecular defects in complementation groups B, C, and D all lead to a deficiency in RFX, a nuclear protein complex that binds to the X box of MHC-II promoters. The lack of RFX binding activity in complementation group C results from mutations in the RFX5 gene encoding the 75-kD subunit of RFX (Steimle et al., 1995). RFX5 is the fifth member of the growing family of DNA-binding proteins sharing a novel and highly characteristic DNA-binding domain called the RFX motif. Multiple alternatively spliced transcript variants have been found but the full-length natures of only two have been determined.A lack of MHC-II expression results in a severe immunodeficiency syndrome called MHC-II deficiency, or the bare lymphocyte syndrome (BLS; MIM 209920). At least 4 complementation groups have been identified in B-cell lines established from patients with BLS. The molecular defects in complementation groups B, C, and D all lead to a deficiency in RFX, a nuclear protein complex that binds to the X box of MHC-II promoters. The lack of RFX binding activity in complementation group C results from mutations in the RFX5 gene encoding the 75-kD subunit of RFX (Steimle et al., 1995). RFX5 is the fifth member of the growing family of DNA-binding proteins sharing a novel and highly characteristic DNA-binding domain called the RFX motif. Multiple alternatively spliced transcript variants have been found but the full-length natures of only two have been determined.
General readings
Nagarajan,U.M., (2004) J. Immunol. 173 (1), 410-419








Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| AP32341PU-N | RFX5 antibody |
||||||
![]() |
Goat | Aff - Purified | Bov, Can, Hu, Ms, Por, Rb, Rt | E, WB |
0.1 mg /
€380.00
|
||
| OriGene Technologies GmbH | |||||||
OriGene recommends this product for Western blotting. |
|||||||
| TA319308 | RFX5 antibody |
||||||
| Rabbit polyclonal anti-RFX5 antibody | |||||||
![]() |
Rabbit | Ig Fraction | Hu, Ms | E, EMSA, IP, WB |
0.1 mg /
€515.00
|
||
| OriGene Technologies, Inc. | |||||||
| R1018 | RFX5 antibody |
||||||
![]() |
Rabbit | Serum | Hu | E, EMSA, IP |
0.1 ml /
€515.00
|
||
| OriGene Technologies GmbH | |||||||
| R1019 | RFX5 antibody |
||||||
![]() |
Rabbit | Ig Fraction | Hu | E, EMSA, IP, WB |
0.1 mg /
€515.00
|
||
| OriGene Technologies GmbH | |||||||
| R1020 | RFX5 antibody |
||||||
![]() |
Rabbit | Serum | Hu, Ms | E, EMSA, IP |
0.1 ml /
€515.00
|
||
| OriGene Technologies GmbH | |||||||
| R1022 | RFX5 (N-term) antibody |
||||||
![]() |
Rabbit | Serum | Hu, Ms | E, EMSA, IP |
0.1 ml /
€515.00
|
||
| OriGene Technologies GmbH | |||||||
| R1023 | RFX5 (N-term) antibody |
||||||
![]() |
Rabbit | Ig Fraction | Hu, Ms | E, EMSA, IP, WB |
0.1 mg /
€515.00
|
||
| OriGene Technologies GmbH | |||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP312448 | RFX5 (transcript variant 2) |
||||
| Recombinant protein of human regulatory factor X, 5 (influences HLA class II expression) (RFX5), transcript variant 2 | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY422455 | RFX5 overexpression lysate |
|
![]() |
0.1 mg /
€495.00
|
|
| OriGene Technologies, Inc. | ||
| LY424713 | RFX5 overexpression lysate |
|
![]() |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY425501 | RFX5 overexpression lysate |
|
![]() |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |





